570 related articles for article (PubMed ID: 7828672)
21. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells.
Apodaca G; Rutka JT; Bouhana K; Berens ME; Giblin JR; Rosenblum ML; McKerrow JH; Banda MJ
Cancer Res; 1990 Apr; 50(8):2322-9. PubMed ID: 2156617
[TBL] [Abstract][Full Text] [Related]
22. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork.
Alexander JP; Samples JR; Van Buskirk EM; Acott TS
Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):172-80. PubMed ID: 1846130
[TBL] [Abstract][Full Text] [Related]
23. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
Teesalu T; Masson R; Basset P; Blasi F; Talarico D
Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases in periodontal tissue remodelling.
Sodek J; Overall CM
Matrix Suppl; 1992; 1():352-62. PubMed ID: 1480060
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin.
Katsuda S; Okada Y; Okada Y; Imai K; Nakanishi I
Am J Pathol; 1994 Nov; 145(5):1208-18. PubMed ID: 7977651
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
Galis ZS; Sukhova GK; Lark MW; Libby P
J Clin Invest; 1994 Dec; 94(6):2493-503. PubMed ID: 7989608
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y
Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123
[TBL] [Abstract][Full Text] [Related]
29. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.
Montgomery AM; De Clerck YA; Langley KE; Reisfeld RA; Mueller BM
Cancer Res; 1993 Feb; 53(3):693-700. PubMed ID: 8425205
[TBL] [Abstract][Full Text] [Related]
30. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
[TBL] [Abstract][Full Text] [Related]
31. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
[TBL] [Abstract][Full Text] [Related]
32. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor.
Muir D
Exp Cell Res; 1994 Feb; 210(2):243-52. PubMed ID: 8299723
[TBL] [Abstract][Full Text] [Related]
33. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses.
Syggelos SA; Eleftheriou SC; Giannopoulou E; Panagiotopoulos E; Aletras AJ
J Rheumatol; 2001 Jun; 28(6):1319-29. PubMed ID: 11409126
[TBL] [Abstract][Full Text] [Related]
34. TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.
Stetler-Stevenson WG; Krutzsch HC; Liotta LA
Matrix Suppl; 1992; 1():299-306. PubMed ID: 1480041
[TBL] [Abstract][Full Text] [Related]
35. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts.
Li L; Akers K; Eisen AZ; Seltzer JL
Exp Cell Res; 1997 May; 232(2):322-30. PubMed ID: 9168808
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
Sugiura Y; Shimada H; Seeger RC; Laug WE; DeClerck YA
Cancer Res; 1998 May; 58(10):2209-16. PubMed ID: 9605768
[TBL] [Abstract][Full Text] [Related]
37. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
Kikkawa F
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
[TBL] [Abstract][Full Text] [Related]
38. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells.
Winwood PJ; Schuppan D; Iredale JP; Kawser CA; Docherty AJ; Arthur MJ
Hepatology; 1995 Jul; 22(1):304-15. PubMed ID: 7601425
[TBL] [Abstract][Full Text] [Related]
39. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor.
DeClerck YA; Yean TD; Chan D; Shimada H; Langley KE
Cancer Res; 1991 Apr; 51(8):2151-7. PubMed ID: 2009533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
